Medical Journals

Expression of the Camp-phosphodiesterase Pde4d Isoforms and Age-related Changes in Follicle-stimulating Hormone-stimulated Pde4 Activities in Immature Rat Sertoli Cells.

Authors:
  • Levallet Guénaëlle
  • Levallet Jérôme
  • Bouraïma-Lelong Hélène
  • Bonnamy Pierre-Jacques

From: EA 2608, INRA USC 2006, Laboratoire Oestrogènes et Reproduction, Université de Caen, 14032 Caen, France.

Biology of reproduction

  • Publish Date: May 2007
  • ISSN: 0006-3363
  • Volume: 76
  • Issue: 5
  • Pages: 794-803
  • Medium: Print
  • Language: English
  • Citation (JAMA): Levallet Guénaëlle, Levallet Jérôme, Bouraïma-Lelong Hélène, et al. Expression of the Camp-phosphodiesterase Pde4d Isoforms and Age-related Changes in Follicle-stimulating Hormone-stimulated Pde4 Activities in Immature Rat Sertoli Cells.. Biol. Reprod. May 2007;76:794-803

Abstract

Major changes in the cAMP-dependent signal transduction pathway triggered by FSH take place during transition of rat Sertoli cells from proliferative to the quiescent/terminally differentiated state. Using Sertoli cell cultures isolated from 10-, 20-, and 30-day-old rats, we recorded a specific increase in PDE4 activity in both the soluble and particulate subcellular fractions of 20-day-old Sertoli cells, which also displayed the highest cAMP response to FSH and the highest FSH-induced increase in PDE4 activity in both subcellular compartments. RT-PCR and immunoblotting experiments showed that almost all the PDE4D isoforms, known as the main cAMP-regulated rolipram-sensitive PDE in Sertoli cells, were expressed throughout the early postpartum period, whereas only the short PDE4D isoforms (PDE4D1 and PDE4D2) were transcriptionally regulated by FSH. Unexpectedly, the immunoblot data also revealed that the soluble PDE4 activities were mainly related to the long PDE4D isoforms and that short PDE4D1 was predominantly particulate. The subcellular distribution and expression of PDE4D proteins were unaffected by the developmental status of the Sertoli cells. Only the expression of short PDE4D1 appeared to be upregulated by FSH and only in 20-day-old Sertoli cells, which suggests phenotype-dependent differential regulation of Pde4d1 mRNA translation. Resensitization of the cAMP response to FSH in 20-day-old Sertoli cells was also associated with the highest FSH-induced transient increase in both soluble and particulate PDE4 activities, which suggests developmental changes in the PKA-mediated upregulation of the catalytic activities of long PDE4D. Such alterations may be involved in the phenotype-dependent alterations in FSH receptor coupling with its associated G proteins in rat Sertoli cells.

Mesh Headings (Keywords): 3’,5’-Cyclic-AMP Phosphodiesterases, Aging, Animals, Blotting, Western, Cyclic Nucleotide Phosphodiesterases, Type 4, DNA Primers, Electrophoresis, Polyacrylamide Gel, Female, Follicle Stimulating Hormone, Isoenzymes, Kinetics, Male, Phosphodiesterase Inhibitors, Protein Isoforms, RNA, Messenger, Rats, Rats, Sprague-Dawley, Reverse Transcriptase Polymerase Chain Reaction, Rolipram, Sertoli Cells, Stimulation, Chemical, Subcellular Fractions


Check for Full Text / PubMed Unique Identifier (PMID): 17215491


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.